Miscellaneous
The understanding, diagnosis, and treatment options for transthyretin (TTR) amyloid is rapidly evolving. American Heart Association published a statement titled "Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association". I have tried to present the key elements of this article. Link: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000792